Aucnet (3964) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Oct, 2026Executive summary
H1 FY2026 net sales rose 16.8% YoY to ¥37,983 million, operating profit rose 21.3% to ¥7,082 million, and profit attributable to owners rose 30.2% to ¥4,820 million.
Lifestyle Products and Mobility & Energy grew; the absence of prior-year stock-based compensation and 40th-anniversary expenses also supported the profit comparison.
Financial highlights
H1 ordinary profit increased 25.1% to ¥7,154 million; EBITDA was ¥7,680 million, up 21.1% YoY.
H1 gross profit was ¥15.71bn versus ¥14.78bn a year earlier; operating profit was ¥7.08bn versus ¥5.84bn.
Q2 standalone net sales rose 19.6% to ¥19,794 million, operating profit 40.1% to ¥3,856 million, and net income 57.5% to ¥2,663 million.
Total assets reached ¥59,734 million at June 30, 2026, up ¥8,950 million from year-end; net assets rose ¥3,330 million to ¥29,954 million.
Outlook and guidance
FY2026 forecast raised to net sales ¥75,000 million, operating profit ¥12,000 million, ordinary profit ¥12,000 million, and net income ¥7,800 million.
Forecast YoY growth is 16.9% for sales, 26.1% for operating profit, 26.0% for ordinary profit, and 31.7% for net income; operating margin is forecast at 16.0% and EPS at ¥85.91.
Blue Print 2027 targets EBITDA of ¥13.5bn, ROE of 15–20%, a payout ratio of at least 50%, and long-term GCV of ¥1tn.
Latest events from Aucnet
- Sales grew, but operating profit fell; FY2024 guidance remained unchanged.3964
Q1 2024 - H1 revenue rose 21.2%, while acquisition costs pressured profit; FY sales guidance rose to ¥58bn.3964
Q2 2024 - 9M sales rose 25.4%, while operating profit grew 3.4%; FY2024 guidance was unchanged.3964
Q3 2024 - FY2024 sales rose 29.1%; FY2025 profit outlook falls amid temporary costs.3964
Q4 2024 - Q1 growth lifted FY2025 forecasts and the dividend outlook to ¥42 per share.3964
Q1 2025 - Lifestyle-led H1 growth lifted operating profit 51.4% and raised FY2025 guidance.3964
Q2 2025 - 9M sales rose 17.4% and operating profit 43.3%; FY2025 guidance was raised.3964
Q3 2025 - FY2025 EBITDA exceeded its FY2027 target early as profit growth accelerated.3964
Q4 2025 - Q1 growth lifted FY2026 earnings forecasts and dividend guidance.3964
Q1 2026